Urine Telomerase Activity for the Detection of Bladder Cancer in Females

Journal of Urology

Volumn 178, Issue 1, 2007, Pages 57-61

  Bravaccini, Sara ^a   Sanchini, Maria Aurora ^a   Granato, Anna Maria ^a   Gunelli, Roberta ^a   Nanni, Oriana ^a   Amadori, Dino ^b   Calistri, Daniele ^a   Silvestrini, Rosella ^a  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

Author keywords

diagnosis; telomerase; urinary bladder neoplasms; urine

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY; TELOMERASE; URINARY BLADDER NEOPLASMS;

EID: 34250305542     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.03.025     Document Type: Article

References (20)

1. Negri E., and LaVecchia C. Epidemiology and prevention of bladder cancer. Eur J Cancer Prev 10 (2001) 7
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74
3. Lotan Y., and Roehrborn C.G. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology 61 (2003) 109
4. Mitropoulos D., Kiroudi-Voulgari A., Nikopoulos P., Manousakas T., and Zervas A. Accuracy of cystoscopy in predicting histologic features of bladder lesions. J Endourol 19 (2005) 861
5. Babjuk M., Kostirova M., Mudra K., Pecher S., Pecher S., Smolova H., et al. Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladder. Eur Urol 41 (2002) 34
6. Laudadio J., Keane T.E., Reeves H.M., Savage S.J., Hoda R.S., Lage J.M., et al. Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice. BJU Int 96 (2005) 1280
7. Kinoshita H., Ogawa O., Kakehi Y., Mishina M., Mitsumori K., Itoh N., et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 89 (1997) 724
8. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011
9. Wright W.E., Shay J.W., and Piatyszek M.A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acid Res 23 (1995) 3794
10. Sanchini M.A., Bravaccini S., Medri L., Gunelli R., Nanni O., Monti F., et al. Urine telomerase: an important marker in the diagnosis of bladder cancer. Neoplasia 6 (2004) 234
11. Gelmini S., Crisci A., Salvadori B., Pazzagli M., Selli C., and Orlando C. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. Clin Cancer Res 6 (2000) 2771
12. Kavaler E., Landman J., Chang Y., Droller M.J., and Liu B.C. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer 82 (1998) 708
13. Sanchini M.A., Gunelli R., Nanni O., Bravaccini S., Fabbri C., Sermasi A., et al. Relevance of urine telomerase in the diagnosis of bladder cancer. JAMA 294 (2005) 2052
14. Fedriga R., Gunelli R., Nanni O., Bacci F., Amadori D., and Calistri D. Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine. Neoplasia 3 (2001) 446
15. Deeks J.J. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323 (2001) 157
16. Moriarty T.J., Ward R.J., Taboski M.A., and Autexier C. An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization. Mol Biol Cell 16 (2005) 3152
17. Ramakumar S., Bhuiyan J., Besse J.A., Roberts S.G., Wollan P.C., Blute D.J., et al. Comparison of screening methods in the detection of bladder cancer. J Urol 161 (1999) 388
18. Oestreicher N., White E., Malone K.E., and Porter P.L. Hormonal factors and breast tumor proliferation; do factors that affect cancer risk also affect tumor growth?. Breast Cancer Res Treat 85 (2004) 133
19. Iwao T., Hiyama E., Yokoyama T., Tsuchida A., Hiyama K., Murakami Y., et al. Telomerase activity for the preoperative diagnosis of pancreatic cancer. J Natl Cancer Inst 89 (1997) 1621
20. Weikert S., Christoph F., Schrader M., Krause H., Miller K., and Muller M. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Int J Cancer 116 (2005) 100